Literature Cited

Course: WB 4342
CE Original Date: March 20, 2020
CE Expiration Date: March 20, 2022
Download Printer-Friendly version pdf icon[PDF – 859 KB]

References
    1. [ACGIH] American Conference of Governmental Industrial Hygienists. 2017. TLVs & BEIs: Threshold limit values for chemical substances and physical agents and biological exposure indices for 2017. American Conference of Governmental Industrial Hygienists, Cincinnatti, OH.
    2. Albertson TE. 1999. Plenty to fear from toxic alcohols. Crit Care Med 27(12):2834-6.
    3. Apple FS, Googins MK, Resen D. 1993. Propylene glycol interference in gas-chromatographic assay of ethylene glycol. Clin Chem 39(1):167.
    4. Arroliga AC, Shehab N, McCarthy K, et al. 2004. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 32(8):1709-14.
    5. [ATSDR] Agency for Toxic Substances and Disease Registry. 1997. Toxicological profile for ethylene glycol and propylene glycol. Atlanta: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services.
    6. [ATSDR] Agency for Toxic Substances and Disease Registry. 2008. Addendum for propylene glycol. Supplement to the 1997 toxicological profile for propylene glycol. Atlanta: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services.
    7. [ATSDR] Agency for Toxic Substances and Disease Registry. 2010. Toxicological profile for ethylene glycol. Atlanta: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services.
    8. [ATSDR] Agency for Toxic Substances and Disease Registry. 2014. Medical management guidelines for ethylene glycol. Atlanta: Agency for Toxic Substances and Disease Registry. Available from: https://www.atsdr.cdc.gov/mmg/mmg.asp?id=82&tid=21.
    9. Barceloux DG, Krenzelok EP, Olson K, et al. 1999. American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol 37(5):537-60.
    10. Barnes BJ, Gerst C, Smith JR, et al. 2006. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 26(1):23-33.
    11. Battistella M. 2002. Fomepizole as an antidote for ethylene glycol poisoning. Ann Pharmacother 36(6):1085-9.
    12. Baud FJ, Galliot M, Astier A, et al. 1988. Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Eng J Med 319(2):97-100.
    13. Baum CR, Langman CB, Oker EE, et al. 2000. Fomepizole treatment of ethylene glycol poisoning in an infant. Pediatrics 106(6):1489-91.
    14. Berman LB, Schreiner GE, Feys J. 1957. The nephrotoxic lesion of ethylene glycol. Ann Intern Med 46(3):611-9.
    15. Bey TA, Walter FG, Gibly RL, et al. 2002. Survival after ethylene glycol poisoning in a patient with an arterial pH of 6.58. Vet Hum Toxicol 44(3):167-8.
    16. Bledsoe KA, Kramer AH. 2008. Propylene glycol toxicity complicating use of barbiturate coma. Neurocrit Care 9(1):122-4.
    17. Borron SW, Megarbane B, Baud FJ. 1999. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet 354(9181):831.
    18. Bove KE. 1966. Ethylene glycol toxicity. Am J Clin Pathol 45(1):46-50.
    19. Boyer EW, Mejia M, Woolf A, et al. 2001. Severe ethylene glycol ingestion treated without hemodialysis. Pediatrics 107(1):172-3.
    20. Brent J. 2001. Current management of ethylene glycol poisoning. Drugs 61(7):979-88.
    21. Brent J. 2010. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol 48(5):401-6.
    22. Brent J, McMartin K, Phillips S, et al. 1999. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med 340(11):832-8.
    23. Broadley SA, Ferguson IT, Walton B, et al. 1997. Severe sensorimotor polyradiculoneuropathy after ingestion of ethylene glycol. J Neurol Neurosurg Psychiatry 63(2):261.
    24. Bronstein AC, Spyker DA, Cantilena LR, Jr., et al. 2009. 2008 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol 47(10):911-1084.
    25. Buchanan JA, Alhelail M, Cetaruk EW, et al. 2010. Massive ethylene glycol ingestion treated with fomepizole alone-a viable therapeutic option. J Med Toxicol 6(2):131-4.
    26. Buell JF, Sterling R, Mandava S, et al. 1998. Ethylene glycol intoxication presenting as a metabolic acidosis associated with a motor vehicle crash: case report. J Trauma 45(4):811-3.
    27. Caravati EM, Erdman AR, Christianson G, et al. 2005. Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 43(5):327-45.
    28. Caravati EM, Heileson HL, Jones M. 2004. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol 42(3):255-9.
    29. Cheng JT, Beysolow TD, Kaul B, et al. 1987. Clearance of ethylene glycol by kidneys and hemodialysis. J Toxicol Clin Toxicol 25(1-2):95-108.
    30. Chung PK, Tuso P. 1989. Cerebral computed tomography in a stage IV ethylene glycol intoxication. Conn Med 53(9):513-4.
    31. Clayton GD, Clayton FE. 1994. Patty’s industrial hygiene and toxicology. Vol. 2, Part F, Toxicology. 4th ed. New York: John Wiley & Sons.
    32. Curtin L, Kraner J, Wine H, et al. 1992. Complete recovery after massive ethylene glycol ingestion. Arch Intern Med 152(6):1311-3.
    33. Davis DP, Bramwell KJ, Hamilton RS, et al. 1997. Ethylene glycol poisoning: case report of a record-high level and a review. J Emerg Med 15(5):653-67.
    34. Demey HE, Daelemans RA, Verpooten GA, et al. 1988. Propylene glycol-induced side effects during intravenous nitroglycerin therapy. Intensive Care Med 14(3):221-6.
    35. Druteika DP, Zed PJ, Ensom MH. 2002. Role of fomepizole in the management of ethylene glycol toxicity. Pharmacotherapy 22(3):365-72.
    36. Eder AF, McGrath CM, Dowdy YG, et al. 1998. Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis. Clin Chem 44(1):168-77.
    37. [EPA] US Environmental Protection Agency. 2000. Ethylene glycol. Washington DC: US Environmental Protection Agency. Available from: https://www.epa.gov/sites/production/files/2016-09/documents/ethylene-glycol.pdf
    38. [EPA] US Environmental Protection Agency. 2007. Clean Air Act. 42 USC Sec. 7412. Hazardous air pollutants. Available from: https://www.gpo.gov/fdsys/pkg/USCODE-2013-title42/html/USCODE-2013-title42-chap85-subchapI-partA-sec7412.htm.
    39. [FDA] US Food and Drug Administration. 2017. 21 CFR 184.1 Direct food substances affirmed as generally recognized as safe. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1.
    40. Fiedler NL. 2007. Organic solvents and fuels. In: Rom, WN, editor. Environmental and occupational medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins.
    41. Ford M GL. 1991. Alcohols and glycols. In: Rippe JM, Irwin RS, Alpert JS, Fink MP, editors. Intensive care medicine. 2nd ed. Boston: Little, Brown and Co. p. 1160-73.
    42. Friedman EA, Greenberg JB, Merrill JP, et al. 1962. Consequences of ethylene glycol poisoning. Report of four cases and review of the literature. Am J Med 32:891-902.
    43. Froberg K, Dorion RP, McMartin KE. 2006. The role of calcium oxalate crystal deposition in cerebral vessels during ethylene glycol poisoning. Clin Toxicol 44(3):315-8.
    44. [FSTRAC] Federal-State Toxicology and Regulatory Alliance Committee. 1990. Summary of state and federal drinking water standards and guidelines. Washington DC: US Environmental Protection Agency. Available from: https://nepis.epa.gov/Exe/ZyPDF.cgi/10003I4B.PDF?Dockey=10003I4B.PDF.
    45. Gabow PA, Clay K, Sullivan JB, et al. 1986. Organic acids in ethylene glycol intoxication. Ann Intern Med 105(1):16-20.
    46. Gardner TB, Manning HL, Beelen AP, et al. 2004. Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal deposition. J Clin Gastroenterol 38(5):435-9.
    47. Glaser DS. 1996. Utility of the serum osmol gap in the diagnosis of methanol or ethylene glycol ingestion. Ann Emerg Med 27(3):343-6.
    48. Godolphin W, Meagher EP, Sanders HD, et al. 1980. Unusual calcium oxalate crystals in ethylene glycol poisoning. Clin Toxicol 16(4):479-86.
    49. Goldfrank LR, Flomenbaum NE, Lewin NA, et al. 1998. Toxic alcohols. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al., editors. Goldfrank’s toxicologic emergencies. Stamford, CT: Appleton and Lange, p. 1049-60.
    50. Goldfrank LR, Nelson LS, et al 2019. Toxic Alcohols. In: Goldfrank’s Toxicologic Emergencies. 11th edition. McGraw-Hill Education, New York. p. 1425.
    51. Gordon HL, Hunter JM. 1982. Ethylene glycol poisoning. A case report. Anaesthesia 37(3):332-8.
    52. Greller H, Gupta A. 2017. Benzodiazepine poisoning and withdrawal. Available from: https://www.uptodate.com/contents/benzodiazepine-poisoning-and-withdrawal
    53. Gummin DD, Mowry JB, Spyker DA, et al. 2016. 2016 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila) 55(10):1072-1254.
    54. Hall AH. 1992. Ethylene glycol and methanol: poisons with toxic metabolic activation. Emerg Med Rpt 13(4):29-38.
    55. Hantson P, Hassoun A, Mahieu P. 1998. Ethylene glycol poisoning treated by intravenous 4-methylpyrazole. Intensive Care Med 24(7):736-9.
    56. Hantson P, Vanbinst R, Mahieu P, et al. 2002. Determination of ethylene glycol tissue content after fatal oral poisoning and pathologic findings. Am J Forensic Med Pathol 23(2):159-61.
    57. Harry P, Jobard E, Briand M, et al. 1998. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Pediatrics 102(3):E31.
    58. Harry P, Turcant A, Bouachour G, et al. 1994. Efficacy of 4-methylpyrazole in ethylene glycol poisoning: clinical and toxicokinetic aspects. Hum Exp Toxicol 13(1):61-4.
    59. Haupt MC, Zull DN, Adams SL. 1988. Massive ethylene glycol poisoning without evidence of crystalluria: a case for early intervention. J Emerg Med 6(4):295-300.
    60. Hess R, Bartels MJ, Pottenger LH. 2004. Ethylene glycol: an estimate of tolerable levels of exposure based on a review of animal and human data. Arch Toxicol 78(12):671-80.
    61. Hilliard NJ, Robinson CA, Hardy R, et al. 2004. Pathologic quiz case: repeated positive ethylene glycol levels by gas chromatography. Central venous line contamination of blood samples by propylene glycol from intravenous lorazepam injections. Arch Pathol Lab Med 128(6):e79-80.
    62. Horinek EL, Kiser TH, Fish DN, et al. 2009. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother 43(12):1964-71.
    63. Howard PH, Boethling RS, Jarvis WF, Meylan WM, Michalenko EM. 1991. Handbook of environmental degradation rates. Cheslsea, MI: Lewis Publishers, Inc., p. 392-3.
    64. Howland M. 2015. Antidotes in depth. In: Hoffman RS, Howland M, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill.
    65. Huhn KM, Rosenberg FM. 1995. Critical clue to ethylene glycol poisoning. CMAJ 152(2):193-5.
    66. [IPCS] International Programme on Chemical Safety. 2002. Ethylene glycol: human health aspects. Concise International Chemical Assessment Document 45. Geneva: World Health Organization. Available from: http://www.inchem.org/documents/cicads/cicads/cicad45.htm
    67. Jacobsen D, Hewlett TP, Webb R, et al. 1988. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med 84(1):145-52.
    68. Jacobsen D, McMartin KE. 1986. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1(5):309-34.
    69. Jacobsen D, McMartin KE. 1997. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 35(2):127-43.
    70. Jammalamadaka D, Raissi S. 2010. Ethylene glycol, methanol and isopropyl alcohol intoxication. Am J Med Sci 339(3):276-81.
    71. Jobard E, Harry P, Turcant A, Roy PM, Allain P. 1996. 4-Methylpyrazole and hemodialysis in ethylene glycol poisoning. J Toxicol Clin Toxicol 34(4):373-7.
    72. Johnson B, Meggs WJ, Bentzel CJ. 1999. Emergency department hemodialysis in a case of severe ethylene glycol poisoning. Ann Emerg Med 33(1):108-10.
    73. Jones AL, Volans G. 1999. Management of self poisoning. BMJ 319(7222):1414-7.
    74. Jones AW, Nilsson L, Gladh SA, et al. 1991. 2,3-Butanediol in plasma from an alcoholic mistakenly identified as ethylene glycol by gas-chromatographic analysis. Clin Chem 37(8):1453-5.
    75. Kahn HS, Brotchner RJ. 1950. A recovery from ethylene glycol (anti-freeze) intoxication; a case of survival and two fatalities from ethylene glycol including autopsy findings. Ann Intern Med 32(2):284-94.
    76. Koga Y, Purssell RA, Lynd LD. 2004. The irrationality of the present use of the osmole gap: applicable physical chemistry principles and recommendations to improve the validity of current practices. Toxicol Rev 23(3):203-11.
    77. Kraut JA, Kurtz I. 2008. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol 3(1):208-25.
    78. Lepik KJ, Levy AR, Sobolev BG, et al. 2009. Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med 53(4):439-50.e10.
    79. Leth PM, Gregersen M. 2005. Ethylene glycol poisoning. Forensic Sci Int 155(2-3):179-84.
    80. Levine M, Curry SC, Ruha AM, et al. 2012. Ethylene glycol elimination kinetics and outcomes in patients managed without hemodialysis. Ann Emerg Med 59(6):527-31.
    81. Lewis LD, Smith BW, Mamourian AC. 1997. Delayed sequelae after acute overdoses or poisonings: cranial neuropathy related to ethylene glycol ingestion. Clin PharmacolTher 61(6):692-9.
    82. Lim TY, Poole RL, Pageler NM. 2014. Propylene glycol toxicity in children. J Pediatr Pharmacol Ther 19(4): 277–82.
    83. Louis S, Kutt H, McDowell F. 1967. The cardiocirculatory changes caused by intravenous Dilantin and its solvent. Am Heart J 74(4):523-9.
    84. Malmlund HO, Berg A, Karlman G, et al. 1991. Considerations for the treatment of ethylene glycol poisoning based on analysis of two cases. J Toxicol Clin Toxicol 29(2):231-40.
    85. Marwick J, Elledge RO, Burtenshaw A. 2012. Ethylene glycol poisoning and the lactate gap. Anaesthesia 67(3):299.
    86. McMartin K. 2009. Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin Toxicol 47(9):859-69.
    87. McMartin KE, Cenac TA. 2000. Toxicity of ethylene glycol metabolites in normal human kidney cells. Ann N Y Acad Sci 919:315-7.
    88. Meng QH, Adeli K, Zello GA, et al. 2010. Elevated lactate in ethylene glycol poisoning: True or false? Clinica Chimica Acta 411(7-8):601-4.
    89. Momont SL, Dahlberg PJ. 1989. Ethylene glycol poisoning. Wisc Med J 88(9):16-20.
    90. Moossavi S, Wadhwa NK, Nord EP. 2003. Recurrent severe anion gap metabolic acidosis secondary to episodic ethylene glycol intoxication. Clin Nephrol 60(3):205-10.
    91. Moreau CL, Kerns W 2nd, Tomaszewski CA, et al. 1998. Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. META Study Group. J Toxicol Clin Toxicol 36(7):659-66.
    92. Morgan BW, Ford MD, Follmer R. 2000. Ethylene glycol ingestion resulting in brainstem and midbrain dysfunction. J Toxicol Clin Toxicol 38(4):445-51.
    93. Neale BW, Mesler EL, Young M, et al. 2005. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Ann Pharmacother 39(10):1732-6.
    94. Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR. 2014. Goldfrank’s toxicological emergencies. 10th ed.  Columbus, OH: McGraw-Hill Education.
    95. [NIOSH] National Institute for Occupational Safety and Health. 2005. NIOSH pocket guide to chemical hazards. Publication No. 2005-149. Washington DC: National Institute for Occupational Safety and Health. Available from: https://www.cdc.gov/niosh/npg/default.html.
    96. [NIOSH] National Institute for Occupational Safety and Health. 2014. Ethylene glycol: systemic agent. Washington DC: National Institute for Occupational Safety and Health. Available from: https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750031.html.
    97. [NLM] US National Library od Medicine. 2016. Household Products Database: Ethylene glycol. Bethesda, MD: US National Library of Medicine. US Department of Health and Human Services. Available from: https://hpd.nlm.nih.gov/cgi-bin/household/search?tbl=TblChemicals&queryx=107-21-1.
    98. O’Donnell J, Mertl SL, Kelly WN. 2000. Propylene glycol toxicity in a pediatric patient: the dangers of diluents. J Pharm Pract 13(3):214-24.
    99. Olivero JJ. 1993. A comatose man with marked acidosis and crystaluria. Hosp Pract (Off Ed) 28(7):86-8.
    100. Parker MG, Fraser GL, Watson DM, et al. 2002. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med 28(1):81-4.
    101. Parry MF, Wallach R. 1974. Ethylene glycol poisoning. Am J Med 57(1):143-50.
    102. Peleg O, Bar-Oz B, Arad I. 1998. Coma in a premature infant associated with the transdermal absorption of propylene glycol. Acta Paediatr 87(11):1195-6.
    103. Pellegrino B, Parravani A, Cook L, et al. 2006. Ethylene glycol intoxication: disparate findings of immediate versus delayed presentation. W V Med J 102(4):32-4.
    104. Piagnerelli M, Carlier E, Lejeune P. 1999. Adult respiratory distress syndrome and medullary toxicity: two unusual complications of ethylene glycol intoxication. Intensive Care Med 25(10):1200.
    105. Pien K, van Vlem B, van Coster R, et al. 2002. An inherited metabolic disorder presenting as ethylene glycol intoxication in a young adult. Am J Forensic Med Pathol 23(1):96-100.
    106. Poldelski V, Johnson A, Wright S, et al. 2001. Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis 38(2):339-48.
    107. Purssell RA, Lynd LD, Koga Y. 2004. The use of the osmole gap as a screening test for the presence of exogenous substances. Toxicol Rev 23(3):189-202.
    108. Rahman SS, Kadakia S, Balsam L, et al. 2012. Autonomic dysfunction as a delayed sequelae of acute ethylene glycol ingestion : a case report and review of the literature. J Med Toxicol 8(2):124-9.
    109. Rasic S, Cengic M, Golemac S, et al. 1999. Acute renal insufficiency after poisoning with ethylene glycol. Nephron 81(1):119-20.
    110. Rhyee SH. 2018. General approach to drug poisoning in adults. Available from: https://www.uptodate.com/contents/general-approach-to-drug-poisoning-in-adults.
    111. Robinson CA, Jr., Scott JW, Ketchum C. 1983. Propylene glycol interference with ethylene glycol procedures. Clin Chem 29(4):727.
    112. Schwerk N, Desel H, Schulz M, et al. 2007. Successful therapy of paediatric ethylene glycol poisoning: a case report and annual survey by a regional poison centre. Acta Paediatr 96(3):461-3.
    113. Seay RE, Graves PJ, Wilkin MK. 1997. Comment: possible toxicity from propylene glycol in lorazepam infusion. Ann Pharmacother 31(5):647-8. Erratum in: Ann Pharmacother 1997;31(11):1413.
    114. Shah RR, De La Calzada-Jeanlouie, Weiselberg RS, Su M. 2013. Chapter 17. Toxicology. In: Shah BR, Lucchesi M, Amodio J, Silverberg M, editors. Atlas of pediatric emergency medicine. 2nd ed. New York: McGraw-Hill.
    115. Singh M, Murtaza M, D’Souza N, et al. 2001. Abdominal pain and lactic acidosis with ethylene glycol poisoning. Am J Emerg Med 19(6):529-30.
    116. Sivilotti MLA. 2018. Methanol and ethylene glycol poisoning. Available from: https://www.uptodate.com/contents/methanol-and-ethylene-glycol-poisoning.
    117. Speth PA, Vree TB, Neilen NF, et al. 1987. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther Drug Monit 9(3):255-8.
    118. Stokes JB, 3rd, Aueron F. 1980. Prevention of organ damage in massive ethylene glycol ingestion. JAMA 243(20):2065-6.
    119. Szerlip HM. 1999. A 27-year-old homeless man with mental obtundation and a metabolic acidosis. Chest 115(5):1447-8.
    120. Takayesu JK, Bazari H, Linshaw M. 2006. Case records of the Massachusetts General Hospital. Case 7-2006. A 47-year-old man with altered mental status and acute renal failure. N Engl J Med 354(10):1065-72. Erratum in: N Engl J Med 2006;355(4):429.
    121. Tietze KJ, Fuchs B. 2018. Sedative-analgesic medications in critically ill adults: Properties, dosage regimens, and adverse effects. Available from: https://www.uptodate.com/contents/sedative-analgesic-medications-in-critically-ill-adults-properties-dosage-regimens-and-adverse-effects.
    122. Tobe TJ, Braam GB, Meulenbelt J, et al. 2002. Ethylene glycol poisoning mimicking Snow White. Lancet 359(9304):444-5.
    123. Vale JA. 1979. Ethylene glycol poisoning. Vet Hum Toxicol 21(Suppl):118-20.
    124. Velez LI. 2017. Approach to the child with occult toxic exposure. Available from: https://www.uptodate.com/contents/approach-to-the-child-with-occult-toxic-exposure.
    125. Velez LI, Gracia R, Neerman MF. 2007. Ethylene glycol poisoning: current diagnostic and management issues. J Emerg Nurs 33(4):342-5.
    126. Verrilli MR, Deyling CL, Pippenger CE, et al. 1987. Fatal ethylene glycol intoxication. Report of a case and review of the literature. Cleve Clin J Med 54(4):289-95.
    127. Walder AD, Tyler CK. 1994. Ethylene glycol antifreeze poisoning. Three case reports and a review of treatment. Anaesthesia 49(11):964-7.
    128. Watson WA. 2000. Ethylene glycol toxicity: closing in on rational, evidence-based treatment. Ann Emerg Med 36(2):139-41.
    129. Wills JH, Coulston F, Harris ES, et al. 1974. Inhalation of aerosolized ethylene glycol by man. Clin Toxicol 7(5):463-76.
    130. Wilson KC, Reardon C, Farber HW. 2000. Propylene glycol toxicity in a patient receiving intravenous diazepam. N Engl J Med 343(11):815.
    131. Wilson KC, Reardon C, Theodore AC, et al. 2005. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 128(3):1674-81.
    132. Yahwak JA, Riker RR, Fraser GL, et al. 2008. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 28(8):984-91.
    133. Yaucher NE, Fish JT, Smith HW, et al. 2003. Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy 23(9):1094-9.
    134. Yorgin PD, Theodorou AA, Al-Uzri A, et al. 1997. Propylene glycol-induced proximal renal tubular cell injury. Am J Kidney Dis 30(1):134-9.
    135. Zar T, Graeber C, Perazella MA. 2007. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial 20(3):217-9.
    136. Zeiss J, Velasco ME, McCann KM, et al. 1989. Cerebral CT of lethal ethylene glycol intoxication with pathologic correlation. AJNR: Am J Neuroradiol 10(2):440-2.
    137. Zosel A, Egelhoff E, Heard K. 2010. Severe lactic acidosis after an iatrogenic propylene glycol overdose. Pharmacotherapy 30(2):219.
Page last reviewed: October 8, 2020